Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$9.6 million.

  • Jaguar Health's Net Income towards Common Stockholders rose 372.22% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.0 million, marking a year-over-year decrease of 825.4%. This contributed to the annual value of -$38.5 million for FY2024, which is 679.9% up from last year.
  • As of Q3 2025, Jaguar Health's Net Income towards Common Stockholders stood at -$9.6 million, which was up 372.22% from -$10.6 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Net Income towards Common Stockholders ranged from a high of -$7.6 million in Q4 2022 and a low of -$18.0 million during Q1 2022
  • Its 5-year average for Net Income towards Common Stockholders is -$11.1 million, with a median of -$10.6 million in 2025.
  • Within the past 5 years, the most significant YoY rise in Jaguar Health's Net Income towards Common Stockholders was 4703.42% (2022), while the steepest drop was 4977.1% (2022).
  • Over the past 5 years, Jaguar Health's Net Income towards Common Stockholders (Quarter) stood at -$14.3 million in 2021, then surged by 47.03% to -$7.6 million in 2022, then decreased by 20.96% to -$9.2 million in 2023, then fell by 11.6% to -$10.2 million in 2024, then rose by 5.73% to -$9.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$9.6 million for Q3 2025, versus -$10.6 million for Q2 2025 and -$10.6 million for Q1 2025.